334 related articles for article (PubMed ID: 25280819)
1. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
[TBL] [Abstract][Full Text] [Related]
2. Intravenous thrombolysis for acute ischemic stroke in a patient receiving rivaroxaban.
Landais A; Ginoux C
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):e73-4. PubMed ID: 25561312
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report.
Chao YT; Hu CJ; Chan L
Medicine (Baltimore); 2019 Feb; 98(8):e14560. PubMed ID: 30813169
[TBL] [Abstract][Full Text] [Related]
5. A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?
Rota E; Bruzzone G; Agosti S; Pastorino R; Morelli N
Medicine (Baltimore); 2017 Dec; 96(51):e9435. PubMed ID: 29390574
[TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
7. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
8. Revascularization for acute ischemic stroke is safe for rivaroxaban users.
Kimura S; Ogata T; Fukae J; Okawa M; Higashi T; Iwaasa M; Inoue T; Tsuboi Y
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):e427-31. PubMed ID: 25149204
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
10. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
11. Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.
Olindo S; Chardonnet M; Renou P; Coignion C; Debruxelles S; Poli M; Sagnier S; Rouanet F; Sibon I
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):454-459. PubMed ID: 29128327
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
Kono S; Yamashita T; Deguchi K; Omote Y; Yunoki T; Sato K; Kurata T; Hishikawa N; Abe K
Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
[TBL] [Abstract][Full Text] [Related]
13. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
[TBL] [Abstract][Full Text] [Related]
15. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
[No Abstract] [Full Text] [Related]
18. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
19. Catastrophic Secondary Infarctions with Onset Seizure Following Tissue Plasminogen Activator Therapy.
Matsuzono K; Nagaoka L; Suzuki M; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Fujimoto S
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):e24-e26. PubMed ID: 30655041
[TBL] [Abstract][Full Text] [Related]
20. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
Ritzenthaler T; Derex L; Davenas C; Bnouhanna W; Farghali A; Mechtouff L; Cho TH; Nighoghossian N
Rev Neurol (Paris); 2015 Sep; 171(8-9):613-5. PubMed ID: 25857461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
